Clinical trial Recruiting at 1 site Interventional Ages 65 to 80

Testing the best intensity of balance training for older adults

Official title: Optimal Intensity of Reactive Balance Training for Healthy Older Adults

Run by Toronto Rehabilitation Institute · NCT06657989 · Data updated 2026-11-12

This study tests whether high-intensity or moderate-intensity balance training helps healthy older adults improve their balance better and faster than a program without training.

Quick facts

Study typeInterventional
Ages65 Years to 80 Years
SexAll
Enrollment96 (estimated)
SponsorToronto Rehabilitation Institute
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJanuary 21, 2025
Main results expectedMarch 1, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 29, 2026
Trial IDNCT06657989 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are community-dwelling older adults aged 65-80 who can stand and walk independently.

Probably not a fit

Patients with neurological conditions affecting balance, severe osteoporosis, or those currently receiving physiotherapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of different intensities of reactive balance training (RBT) in improving balance reactions among healthy older adults aged 65-80. Participants will engage in either high-intensity or moderate-intensity RBT, or a control program without RBT, to determine which approach leads to faster improvements in balance. The study will also assess the longevity of these improvements after the training concludes. By comparing the outcomes of varying training intensities, the research aims to identify the optimal approach for enhancing balance and reducing fall risk in older adults.

Why it matters

Potential benefit: If successful, this study could lead to more effective balance training programs that significantly reduce the risk of falls in older adults.

How similar studies have gone: Previous studies on reactive balance training have shown varying results, making this investigation into optimal intensity a valuable and potentially novel contribution to the field.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Community-dwelling older adults (65-80 years old)

Exclusion Criteria:

* Unable to stand independently without upper-limb support for \>30 seconds and/or walk independently (without a gait aid) for ≥10 metres;
* Diagnosed neurological condition that could affect balance control (e.g., stroke, Parkinson's disease);
* Score below normative values on the Montreal Cognitive Assessment;
* Score below age-matched normative values for sensory and motor function, as assessed using the FallScreen battery;
* Have insufficient English language comprehension such that they cannot understand instructions;
* Have contraindications to reactive balance training such as severe osteoporosis; and/or
* Are currently attending physiotherapy or supervised exercise.

Where it's running

  • University Health Network
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Avril Mansfield, PhD — University Health Network, Toronto
  • Study coordinator: Avril Mansfield, PhD
  • Email: avril.mansfield@uhn.ca
  • Phone: 416-597-3422

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.